Walleye Capital LLC Kezar Life Sciences, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.08 - $2.54 $56,809 - $133,606	-52,601 Reduced 12.26%	376,580 $448,000
Q2 2023 Aug 14, 2023	BUY	$2.31 - $3.06 $416,809 - $552,137	180,437 Added 72.54%	429,181 $1.05 Million
Q1 2023 May 15, 2023	BUY	$3.13 - $7.31 $778,568 - $1.82 Million	248,744 New	248,744 $778,000
Q1 2022 May 16, 2022	SELL	$12.3 - $18.33 $407,203 - $606,832	-33,106 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$7.44 - $16.72 $246,308 - $553,532	33,106 New	33,106 $553,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $449M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.